Tosin Dada

Dr. Tosin Dada serves as Founder, President and Chief Technology Officer of GMJ Technologies, a Seattle-based leader in novel microscale analytical technologies. With over 15 years of experience in analytical instrument development and applications in bioanalysis, Dr. Dada brings deep expertise in separation science, spectroscopy, optics, and mass spectrometry to advance the company's mission in life sciences and biomedical applications.

Dr. Dada holds a Doctor of Philosophy in Chemistry from Utah State University, earned between 2004 and 2008. His professional background includes experience at Seattle Genetics and the University of Notre Dame, where he developed expertise in analytical chemistry and proteomics methodologies that would become central to GMJ's technology platform.

GMJ Technologies develops next-generation capillary electrophoresis with mass spectrometry (CE-ESI-MS) instruments and related products for life science applications. The company's novel technology integrates capillary electrophoresis and optical-electrospray ionization, interfaceable to any mass spectrometer (CE-OptoESI-MS), addressing critical bottlenecks in protein analysis workflows for research, development, and manufacturing.

Career history

• Founder, President and Chief Technology Officer, GMJ Technologies (2018–present)
• University of Notre Dame, Department of Chemistry and Biochemistry
• Seattle Genetics

What Dr. Dada could bring to his continued role as President and CTO: Dr. Dada's dual expertise spanning academic research in analytical chemistry, biotech industry experience at Seattle Genetics, and founding leadership at GMJ positions him uniquely to advance the commercialization and scientific validation of proprietary CE-OptoESI-MS technology. His technical foundation in mass spectrometry, separation science, and instrumentation development—combined with over 15 years of bioanalytical experience—enables him to drive both R&D innovation and strategic partnerships necessary to establish GMJ's platform as a category leader in proteomics and biopharmaceutical testing workflows.